Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus

Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus

Show other versions (1)

Poniatowskaya T. Yu. Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus. Journal of Education, Health and Sport. 2015;5(3):55-61. ISSN 2391-8306. DOI: 10.5281/zenodo.16210 http://ojs.ukw.edu.pl/index.php/johs/articl...

Full description

Bibliographic Details
Main Author:	T. Yu. Poniatowskaya
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2015-03-01
Series:	Journal of Education, Health and Sport
Subjects:	type 2 diabetes mellitus, hypertension, i / d polymorphism of the gene ace, pharmacogenetics, losartan
Online Access:	http://www.ojs.ukw.edu.pl/index.php/johs/article/view/2580

Similar Items

Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus
by: T. Yu. Poniatowskaya
Published: (2015-03-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
by: Ol'ga Konstantinovna Vikulova, et al.
Published: (2009-09-01)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
by: Darcy Adin, et al.
Published: (2020-03-01)

Angiotensin II type 1 receptor gene polymorphism could influence renoprotective response to losartan treatment in type 1 diabetic patients with high urinary albumin excretion rate
by: Dragović Tamara, et al.
Published: (2010-01-01)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
by: Galina Anatol'evna Baryshnikova, et al.
Published: (2009-03-01)

The association between the insertion/deletion polymorphism of the angiotensin converting enzyme gene and hypertension, as well as environmental, biochemical and anthropometric factors
by: Lucyna Pachocka, et al.
Published: (2020-06-01)

Quantitative ultrastructural characteristics of platelets in the patients with diabetes mellitus type 2 in a compensation with arterial hypertension under correction of arterial blood pressure with losartan
by: Pertseva N.O.
Published: (2011-01-01)

Polymorphism of angiotensin-converting enzyme (rs4340) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus
by: Šeruga M, et al.
Published: (2016-12-01)

Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01)

No Association of Angiotensin-Converting Enzyme Insertion/Deletion (ACE I/D) Gene Polymorphism in the Susceptibility to Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients: An Updated Meta-Analysis
by: Aline Ruilowa de Pinho Coelho, et al.
Published: (2023-08-01)

INFLUENCE OF N-ACETYLCYSTEINE AND LOSARTAN ON THE EARLY ELECTROCARDIOGRAPHIC CHANGES IN RATS WITH STREPTOZOTOCIN TYPE 1 DIABETES MELLITUS
by: I. Sytnyk, et al.
Published: (2016-09-01)

Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus
by: A T Teplyakov, et al.
Published: (2009-03-01)

Dynamics of morphological changes of platelet granules in patients with hypertension and high cardiovascular risk in applying losartan potassium
by: Tverdokhleb I.V., et al.
Published: (2014-06-01)

Dynamics of erythrocyte surface cellular composition in patients with diabetes mellitus type 2 with arterial hypertension under correction of arterial blood pressure with losartan
by: Dzyak G.V., et al.
Published: (2013-01-01)

The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension
by: Gülay Sain Güven, et al.
Published: (2022-09-01)

Association Between Polymorphism of the Angiotensin I Converting Enzyme Gene and Hypertension in Turkish Type II Diabetic Patients
by: Mustafa Araz, et al.
Published: (2001-01-01)

Ultrastructural features of platelets in the patients with diabetes mellitus type 2 in a decompensation with arterial hypertension under correction of arterial blood pressure with losartan
by: Pertseva N.O.
Published: (2012-01-01)

Association of angiotensin-converting enzyme gene polymorphism with pulse pressure and its interaction with obesity status in Heilongjiang province
by: Ningning Wang, et al.
Published: (2019-01-01)

Comparison of Anti Hypertensive Effect of Fixed Dose Enalapril and Losartan in Essential Hypertension
by: Khurram Mansoor
Published: (2009-06-01)

INFLUENCE OF N-ACETYLCYSTEINE AND LOSARTAN ON MODULATION OF CYTOPROTECTIVE AUTOPHAGY IN MYOCARDIUM OF RATS WITH EXPERIMENTAL TYPE 1 DIABETES MELLITUS (FOR ELECTRONIC MICROSCOPY EXPLANATION)
by: I.M. Sytnyk, et al.
Published: (2017-09-01)

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study
by: Lee Hae-Young, et al.
Published: (2011-10-01)

Role of Angiotensin-Converting Enzyme (ACE) gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction
by: Nagaraja Moorthy, et al.
Published: (2021-02-01)

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
by: Gabriel Mulinari-Santos, et al.

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
by: Ali Akbar Nekooeian, et al.
Published: (2021-05-01)

Angiotensin I converting enzyme gene polymorphisms and risk of psychiatric disorders
by: Mohammadarian Akbari, et al.
Published: (2022-05-01)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
by: Goran Kekovic, et al.
Published: (2012-01-01)

Association of angiotensin-converting enzyme activity and polymorphism with echocardiographic measures in familial and nonfamilial hypertrophic cardiomyopathy
by: P.C. Buck, et al.
Published: (2009-08-01)

Determination of Losartan and Losartan Carboxylic acid in Human Plasma by New HPLC Method with Fluorescence Detection for Pharmacokinetics Studies
by: Ahmed Abbas Hussein
Published: (2014-12-01)

Antihypertensive and antihyperglycemic effects of combinations of losartan with metformin and/or glibenclamide in desoxycorticosterone acetate and streptozotocin-induced hypertensive diabetic rats
by: Emuesiri Goodies Moke, et al.
Published: (2023-04-01)

Effectiveness of antihypertensive agents in stage I/II hypertensive patients with ace (I/D) gene polymorphism
by: Bansal G, et al.
Published: (2023-01-01)

Re-evaluating serum angiotensin-converting enzyme in sarcoidosis
by: Shi-yue Zheng, et al.
Published: (2023-10-01)

The Role of Angiotensin-Converting Enzyme (ACE) Polymorphisms in the Risk of Development and Treatment of Diabetic Nephropathy
by: Magdalena Król-Kulikowska, et al.
Published: (2024-02-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

Changes of and genes in the left ventricle of spontaneously hypertensive rat after losartan treatment
by: Hyeryon Lee, et al.
Published: (2019-03-01)

Type 2 diabetes mellitus: Clinical aspects of genetics, nutrigenetics, and pharmacogenetics
by: A S Ametov, et al.
Published: (2015-08-01)

Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian subjects
by: Vasudevan, Ramachandran, et al.
Published: (2008)

Effect of Losartan and Atenolol on heart rate variability in newly diagnosed essential hypertensive patient
by: Shamima Sultana, et al.
Published: (2016-08-01)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
by: Tenenbaum Alexander, et al.
Published: (2002-04-01)

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia
by: S V Nedogoda, et al.
Published: (2012-12-01)

A Comparative Study of Tolerability of Losartan versus Atenolol in Essential Hypertension and Their Effect on Lipid Profile
by: Amrutha Torvi, et al.
Published: (2021-12-01)